Skip to content
SHORLA ONCOLOGY
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact

Company Updates

Shorla Oncology at ASCO Annual Meeting, Chicago 2022

May 30th 2022

Read More

Our CCO, Nicholas Holsman speaks at the MassBio Conference

May 25th 2022May 5th 2022

Read More

Shorla Oncology Appoints Dennis Purcell as Chairman

April 1st 2022March 29th 2022

Read More

Company Name Change: Shorla Pharma is now Shorla Oncology!

March 10th 2022

Read More

Shorla Oncology at Bio CEO & Investor conference, New York 2022

March 4th 2022February 14th 2022

Read More

Shorla Oncology at Euronext IPO ready programme, Dublin 2022

March 7th 2022February 14th 2022

Read More

Shorla Oncology at ASH, Atlanta, Georgia 2021

March 7th 2022December 2nd 2021

Read More

CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston

March 7th 2022November 4th 2021

Read More

Shorla Oncology at CPhI Worldwide in Milan

March 7th 2022November 1st 2021

Read More

Older posts
Newer posts
Page1 Page2 Page3 … Page7

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology®

 

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2022

© 2023 SHORLA ONCOLOGY • Built with GeneratePress
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact